Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes

por Cheng, Hsiu-Chung, Chang, Tsung-Kun, Su, Wei-Chih, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2021

Ectopic pancreas mimicking gastric submucosal tumour treated using robotic surgery

por Chang, Tsung-Kun, Huang, Ching-Wen, Ma, Cheng-Jen, Su, Wei-Chih, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2020

Comparing efficacy and safety between Naldebain(®) and intravenous patient-controlled analgesia with fentanyl for pain management post-laparotomy: study protocol for a randomized c...

por Tsai, Hsiang-Lin, Chang, Tsung-Kun, Su, Wei-Chih, Yeh, Yung-Sung, Huang, Ching-Wen, Ma, Cheng-Jen, Wang, Jaw-Yuan
Publicado 2019

Smartband Use During Enhanced Recovery After Surgery Facilitates Inpatient Recuperation Following Minimally Invasive Colorectal Surgery

por Yin, Tzu-Chieh, Huang, Ching-Wen, Tsai, Hsiang-Lin, Su, Wei-Chih, Ma, Cheng-Jen, Chang, Tsung-Kun, Wang, Jaw-Yuan
Publicado 2021

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

por Yeh, Jen-Hao, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Huang, Ching-Wen, Chang, Tsung-Kun, Su, Wei-Chih, Wang, Jaw-Yuan
Publicado 2022

Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting()()()

por Ma, Cheng-Jen, Huang, Ching-Wen, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Su, Wei-Chih, Yeh, Yung-Sung, Chen, Po-Jung, Wang, Jaw-Yuan
Publicado 2018

Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer pati...

por Ma, Cheng-Jen, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Su, Wei-Chih, Huang, Ching-Wen, Yeh, Yung-Sung, Chang, Yu-Tang, Wang, Jaw-Yuan
Publicado 2019

Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer

por Huang, Chun-Ming, Huang, Ching-Wen, Ma, Cheng-Jen, Tsai, Hsiang-Lin, Su, Wei-Chih, Chang, Tsung-Kun, Huang, Ming-Yii, Wang, Jaw Yuan
Publicado 2020

Effects of Good Pain Management (GPM) ward program on patterns of care and pain control in patients with cancer pain in Taiwan

por Su, Wei-Chih, Chuang, Chieh-Han, Chen, Fang-Ming, Tsai, Hsiang-Lin, Huang, Ching-Wen, Chang, Tsung-Kun, Hou, Ming-Feng, Wang, Jaw-Yuan
Publicado 2020

Low Ligation Plus High Dissection Versus High Ligation of the Inferior Mesenteric Artery in Sigmoid Colon and Rectal Cancer Surgery: A Meta-Analysis

por Yin, Tzu-Chieh, Chen, Yen-Cheng, Su, Wei-Chih, Chen, Po-Jung, Chang, Tsung-Kun, Huang, Ching-Wen, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2021

An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progr...

por Tsai, Hsiang-Lin, Huang, Ching-Wen, Ma, Cheng-Jen, Su, Wei-Chih, Chang, Tsung-Kun, Chen, Po-Jung, Yeh, Yung-Sung, Wang, Jaw-Yuan
Publicado 2019

Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer

por Chuang, Jen-Pin, Tsai, Hsiang-Lin, Chen, Po-Jung, Chang, Tsung-Kun, Su, Wei-Chih, Yeh, Yung-Sung, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2022

Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution

por Chang, Tsung-Kun, Su, Wei-Chih, Chen, Yen-Cheng, Chen, Po-Jung, Li, Ching-Chun, Yeh, Yung-Sung, Huang, Ching-Wen, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Publicado 2022

Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy

por YEH, YUNG-SUNG, TSAI, HSIANG-LIN, CHEN, YEN-CHENG, SU, WEI-CHIH, CHEN, PO-JUNG, CHANG, TSUNG-KUN, LI, CHING-CHUN, HUANG, CHING-WEN, WANG, JAW-YUAN
Publicado 2023

The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind,...

por Tsai, Hsiang-Lin, Yeh, Yung-Sung, Chen, Po-Jung, Chang, Yu-Tang, Chen, Yen-Cheng, Su, Wei-Chih, Chang, Tsung-Kun, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2023

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemothe...

por Yang, I-Ping, Miao, Zhi-Feng, Huang, Ching-Wen, Tsai, Hsiang-Lin, Yeh, Yung-Sung, Su, Wei-Chih, Chang, Tsung-Kun, Chang, Se-fen, Wang, Jaw-Yuan
Publicado 2019

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiothe...

por Huang, Chun-Ming, Huang, Ming-Yii, Tsai, Hsiang-Lin, Huang, Ching-Wen, Su, Wei-Chih, Chang, Tsung-Kun, Chen, Yen-Cheng, Li, Ching-Chun, Wang, Jaw-Yuan
Publicado 2021

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIR...

por Tsai, Hsiang-Lin, Chen, Yen-Cheng, Yin, Tzu-Chieh, Su, Wei-Chih, Chen, Po-Jung, Chang, Tsung-Kun, Li, Ching-Chun, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2022

Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series

por Tsai, Hsiang-Lin, Chen, Po-Jung, Chen, Yen-Cheng, Li, Ching-Chun, Chang, Tsung-Kun, Su, Wei-Chih, Yin, Tzu-Chieh, Huang, Ching-Wen, Wang, Jaw-Yuan
Publicado 2022

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Respon...

por Huang, Chun-Ming, Huang, Ching-Wen, Ma, Cheng-Jen, Yeh, Yung-Sung, Su, Wei-Chih, Chang, Tsung-Kun, Tsai, Hsiang-Lin, Juo, Suh-Hang, Huang, Ming-Yii, Wang, Jaw-Yuan
Publicado 2020